Cargando…
5HT6 Antagonists in the Treatment of Alzheimer’s Dementia: Current Progress
Alzheimer’s disease is an important condition with a considerable and unmet disease burden in large need of continued research and more treatment options. The 5HT6 antagonists are a new class of medications to be offered. Because they are pro-cholinergic, these medications are to be used as adjuncts...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990506/ https://www.ncbi.nlm.nih.gov/pubmed/29728891 http://dx.doi.org/10.1007/s40120-018-0095-y |